Impella vs. IABP in Non-emergent High-Risk PCI: Outcomes and LVEF Recovery from a Large US EHR Study
In contemporary, non-protocolized, non-emergent HR-PCI, the use of Impella was associated with improved outcomes and greater LVEF recovery compared to IABP.
Authors
- Jason Wollmuth (ORCID: https://orcid.org/0000-0002-9102-6075)
- Ali Almedhychy
- Aditya Bharadwaj (ORCID: https://orcid.org/0000-0002-3911-0579)
- William W. O’Neill (ORCID: https://orcid.org/0009-0000-5896-728X)
- Nudrat Noor
Institutions
- Loma Linda University Medical Center (US)
- Johnson & Johnson (United States) (US)
- Henry Ford Health System (US)
- Loma Linda University (US)
- Providence Health & Services (US)
Publication Details
- Journal
- Cardiology and Therapy
- Published
- 2025-12-13
- DOI
- https://doi.org/10.1007/s40119-025-00441-5
- Primary Topic
- Cardiac Imaging and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Abiomed